Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00169_DB00910_nanopub.RAQxo5peQLhl-UPGTImsdP-_j7w3W8atzd2RjY5XL9bPk#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00169_DB00910 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00169_DB00910 label "DDI between Cholecalciferol and Paricalcitol - Vitamin D analogs may enhance the adverse/toxic effect of other Vitamin D analogs. Avoid combined use of multiple vitamin D analogs (at pharmacologic doses). Prescribing information for calcitriol, doxercalciferol, paricalcitol, and alfacalcidol each specifically cautions against such combined use. Though not specified in the prescribing information for calcipotriene, cholecalciferol, and ergocalciferol, each contains warnings regarding the potential for vitamin D toxicity. [drugbank_resource:DB00169_DB00910]" assertion.
- drugbank_resource:DB00169_DB00910 identifier "drugbank_resource:DB00169_DB00910" assertion.
- drugbank_resource:DB00169_DB00910 title "DDI between Cholecalciferol and Paricalcitol - Vitamin D analogs may enhance the adverse/toxic effect of other Vitamin D analogs. Avoid combined use of multiple vitamin D analogs (at pharmacologic doses). Prescribing information for calcitriol, doxercalciferol, paricalcitol, and alfacalcidol each specifically cautions against such combined use. Though not specified in the prescribing information for calcipotriene, cholecalciferol, and ergocalciferol, each contains warnings regarding the potential for vitamin D toxicity." assertion.
- drugbank:DB00910 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00169_DB00910 assertion.
- drugbank:DB00169 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00169_DB00910 assertion.